Management Of Worsening Heart Failure With Subcutaneous Furosemide In A High-risk Ambulatory Patient Cohort

被引：0
|
作者：
Patel, Hamza [1 ]
Riley, Sarah [2 ]
Dorsey, Elissa [1 ]
Chambers, Julianne [1 ]
Barkdoll, Jessica [3 ]
Xie, Michelle m [1 ]
Babola, Natalie [1 ]
Thomas, Kamishia [4 ]
Awuah-asamoah, Ama [1 ]
Henry, Leeann [1 ]
Heisler, Kara [1 ]
Cuomo, Kimberly
Gilotra, Nisha [5 ]
机构：
[1] Johns Hopkins Univ Hosp, BALTIMORE, MD USA
[2] Johns Hopkins Univ, Sch Med, Glenwood, MD USA
[3] Johns Hopkins Univ Hosp, York, PA USA
[4] Johns Hopkins Univ Hosp, Lanham, MD USA
[5] Johns Hopkins Univ, Sch Med, Ellicott City, MD USA
来源：
JOURNAL OF CARDIAC FAILURE | 2025年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
323
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population
    Matsue, Yuya
    Suzuki, Makoto
    Seya, Mie
    Iwatsuka, Ryota
    Mizukami, Akira
    Nagahori, Wataru
    Ohno, Masakazu
    Matsumura, Akihiko
    Hashimoto, Yuji
    JOURNAL OF CARDIOLOGY, 2013, 61 (1-2) : 169 - 174
  • [22] Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure
    Picazo Sanchez, Montserrat
    Castillo Lorenzo, Marlen N.
    Cuxart Perez, Marc
    Sans Lorman, Ramon
    NEFROLOGIA, 2018, 38 (04): : 438 - 439
  • [23] Outpatient treatment of heart failure decompensation with subcutaneous furosemide
    Robles Mezcua, A.
    Martin De La Rosa, A. P.
    Cruzado Alvarez, C.
    Jimenez Rubio, C.
    Perez Cabeza, A. I.
    Garcia Pinilla, J. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 248 - 249
  • [24] Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure
    Wehbe, Ramsey M.
    Khan, Sadiya S.
    Shah, Sanjiv J.
    Ahmad, Faraz S.
    HEART FAILURE CLINICS, 2020, 16 (04) : 387 - 407
  • [25] Subcutaneous Furosemide Therapy for Chronic Management of Refractory Congestive Heart Failure in Dogs and Cats
    Lombardo, Sergio F.
    Ferasin, Heidi
    Ferasin, Luca
    ANIMALS, 2025, 15 (03):
  • [26] Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?
    Zacharias, Hannah
    Raw, Janet
    Nunn, Anne
    Parsons, Sharon
    Johnson, Miriam
    PALLIATIVE MEDICINE, 2011, 25 (06) : 658 - 663
  • [27] Cardiac And Inflammatory Biomarkers And New Or Worsening Heart Failure In High-risk Patients With COVID-19
    Namdaran, Parhum
    Findlay, Matthew
    Gibbs, Jeff
    Dranow, Elizabeth
    Shah, Rashmee
    Drakos, Stavros
    Shaw, Robin
    Fang, James
    Shah, Kevin
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S96 - S96
  • [28] Management of dyslipidemia in the high-risk patient
    Stein, EA
    AMERICAN HEART JOURNAL, 2002, 144 (06) : S43 - S50
  • [29] MANAGEMENT OF LABOR IN THE HIGH-RISK PATIENT
    BENDEL, RP
    MINNESOTA MEDICINE, 1979, 62 (02) : 133 - 134
  • [30] Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management
    Goetze, Stephan
    Zhang, Yi
    An, Qi
    Averina, Viktoria
    Lambiase, Pier
    Schilling, Richard
    Trappe, Hans-Joachim
    Winter, Siegmund
    Wold, Nicholas
    Manola, Ljubomir
    Kestens, Dries
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2015, 43 (01) : 21 - 29
12345